HCA Healthcare price target raised to $555 from $525 at RBC Capital

Core Viewpoint - RBC Capital has raised the price target for HCA Healthcare to $555 from $525 while maintaining an Outperform rating on the shares, indicating positive sentiment towards the company's performance and future outlook [1]. Financial Performance - HCA Healthcare's Q4 results were strong, leading to a favorable reaction in the stock price [1]. - The 2026 full-year outlook is better than expected, reflecting improved core performance [1]. Cost Savings - The company is expected to achieve $400 million in savings from resiliency efforts, which will more than offset the expiration of the ePTC and the lower contribution from state supplemental programs [1].